Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v4-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2026-03-20 | 2026-03-20 |
| Drug Identification Number | 02532379 | 02532379 |
| Brand name | GLYCOPYRROLATE INJECTION USP | GLYCOPYRROLATE INJECTION USP |
| Common or Proper name | Glycopyrrolate Injection | Glycopyrrolate Injection |
| Company Name | JAMP PHARMA CORPORATION | JAMP PHARMA CORPORATION |
| Ingredients | GLYCOPYRROLATE | GLYCOPYRROLATE |
| Strength(s) | 0.2MG | 0.2MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 20 mL | 20 mL |
| Additional packaging sizes | ||
| ATC code | A03AB | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage (Changed) | Updated to: Disruption of the manufacture of the drug. | Was: Other (Please describe in comments) |
| Anticipated start date | ||
| Actual start date | 2026-03-12 | 2026-03-12 |
| Estimated end date (Changed) | Updated to: 2026-04-10 | Was: 2026-03-13 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments (Changed) | Updated to: Allocation | Was: Allocation, Manufacturer delay |
| Health Canada comments |